Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 17 2019 - 4:05PM
Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today
announced that on September 12, 2019, the Compensation Committee of
the Company’s Board of Directors approved equity award grants under
the Sientra, Inc. Inducement Plan to 13 new employees.
The new employees were granted restricted stock
units representing a total of 97,187 shares of common stock. The
restricted stock units will vest in three equal annual installments
beginning on each individual employee’s hiring date. In each case,
the vesting of shares is contingent upon the individual’s continued
employment with the Company through each vesting date.
The grants were made as an inducement that was a
material component of each person’s compensation and subsequent
acceptance of employment with the Company or joining Sientra’s
subsidiary, miraDry, Inc., and were granted as an employment
inducement award pursuant to NASDAQ Listing Rule 5635(c)(4)
approved by the Compensation Committee.
About Sientra
Headquartered in Santa Barbara, California,
Sientra is a diversified global medical aesthetics company and a
leading partner to aesthetic physicians. The Company offers a suite
of products designed to make a difference in patients' lives by
enhancing their body image, growing their self-esteem, and
restoring their confidence. Sientra has developed a broad portfolio
of products with technologically differentiated characteristics,
supported by independent laboratory testing and strong clinical
trial outcomes. The Company’s Breast Products Segment includes its
OPUS™ breast implants, the first fifth generation breast implants
approved by the FDA for sale in the United States, its
ground-breaking Allox2® breast tissue expander with patented
dual-port and integral drain technology, and BIOCORNEUM® the #1
performing, preferred and recommended scar gel of plastic
surgeons(*). The Company’s miraDry Segment, comprises its miraDry®
system, which is approved for sale in over 40 international
markets, and is the only non-surgical FDA-cleared device for the
permanent reduction of underarm sweat, odor and hair of all
colors.
(*) Data on file
Investor Relations
805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Apr 2023 to Apr 2024